Related Experiment Video

Updated: May 19, 2026

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

Mastocytosis in children and adults: clinical disease heterogeneity

Magdalena Lange1, Bogusław Nedoszytko, Aleksandra Górska

  • 1Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland.

Archives of Medical Science : AMS
|August 2, 2012
PubMed

Insights

Mastocytosis is a rare clonal disorder involving abnormal mast cell accumulation. This overview aids in diagnosing and managing mast cell disorders across pediatric and adult populations.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Mastocytosis is a rare clonal disorder of hematopoietic stem cells.
  • Characterized by pathological mast cell accumulation in various tissues.
  • Manifests heterogeneously in children (often cutaneous, transient) and adults (often systemic).

Purpose of the Study:

  • To provide a comprehensive overview of mastocytosis.
  • To detail clinical symptoms, diagnostic criteria, and treatment options.
  • To facilitate diagnosis and management in clinical practice.

Main Methods:

  • Literature review of mastocytosis clinical presentation.
  • Analysis of diagnostic criteria for mastocytosis.
  • Summary of current treatment strategies for mastocytosis.

Main Results:

  • Clinical presentation varies based on mast cell burden, mediator release, skin lesions, age, and associated hematological disorders.
  • Diagnostic criteria encompass clinical and laboratory findings.
  • Treatment approaches are tailored to disease subtype and severity.

Conclusions:

  • Mastocytosis requires a multidisciplinary approach due to its heterogeneity.
  • Effective management relies on accurate diagnosis and individualized treatment plans.
  • This overview serves as a clinical guide for healthcare professionals.

Keywords:
adultschildrenclassificationclinicsmastocytosistreatment

More Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...